Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 23306J309 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
Baker Bros. Advisors LP
13D/A
|
10.0% |
1/14/2026
Event 1/12/2026
|
||
| Baker Bros. Advisors LP | 10.0% | |||
| Baker Bros. Advisors (GP) LLC | 10.0% | |||
| Julian C. Baker | 10.0% | |||
| Felix J. Baker | 10.0% | |||
|
Suvretta Capital Management, LLC
13G
|
9.9% |
4/11/2025
Event 4/7/2025
|
||
| Suvretta Capital Management, LLC | 9.9% | |||
| Aaron Cowen | 9.9% | |||
| Averill Master Fund, Ltd. | 8.8% | |||
|
Adage Capital Management, L.P.
13G/A
|
7.3% |
5/13/2026
Event 3/31/2026
|
||
| Adage Capital Management, L.P. | 7.3% | |||
| Robert Atchinson | 7.3% | |||
| Phillip Gross | 7.3% | |||
|
Invus Global Management, LLC
13G/A
|
6.5% |
5/5/2026
Event 3/31/2026
|
||
| Invus Public Equities, L.P. | 6.1% | |||
| Invus Public Equities Advisors, LLC | 6.1% | |||
| Invus Global Management, LLC | 6.1% | |||
| Siren, L.L.C. | 6.1% | |||
| Avicenna Life Sci Master Fund LP | 0.4% | |||
| Avicenna Life Sci Master GP LLC | 0.4% | |||
| Ulys, L.L.C. | 0.4% | |||
| Raymond Debbane | 6.5% | |||
| MPM BioImpact LLC 13G/A | 6.2% |
8/14/2026
Event 6/30/2026
|
||
|
RA Capital Management, L.P.
13G
|
5.8% |
8/6/2026
Event 7/30/2026
|
||
| RA Capital Management, L.P. | 5.8% | |||
| Peter Kolchinsky | 5.8% | |||
| Rajeev Shah | 5.8% | |||
| RA Capital Healthcare Fund, L.P. | 5.8% | |||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (6) | ||||
|
Citadel Advisors LLC
13G
|
6.4% |
4/14/2025
Event 4/7/2025
|
||
| Citadel Advisors LLC | 6.4% | |||
| Citadel Advisors Holdings LP | 6.4% | |||
| Citadel GP LLC | 6.4% | |||
| Citadel Securities LLC | 0% | |||
| Citadel Securities Group LP | 0% | |||
| Citadel Securities GP LLC | 0% | |||
| Kenneth Griffin | 6.4% | |||
|
Bpifrance Participations SA
13D/A
|
4.7% |
1/7/2026
Event 1/5/2026
|
||
| Bpifrance Participations S.A. | 4.6% | |||
| Innobio FPCI | 0.1% | |||
| Bpifrance Investissement SAS | 0.1% | |||
| Caisse des Depots | 4.7% | |||
| EPIC Bpifrance | 4.7% | |||
| Bpifrance S.A. | 4.7% | |||
|
Vivo Opportunity Fund Holdings, L.P.
13G/A
|
4.0% |
5/12/2026
Event 3/31/2026
|
||
| Vivo Opportunity Fund Holdings, L.P. | 4.0% | |||
| Vivo Opportunity, LLC | 4.0% | |||
| Vivo Opportunity Cayman Fund, L.P. | 0.5% | |||
| Vivo Opportunity Cayman, LLC | 0.5% | |||
|
Artisan Partners Limited Partnership
13G/A
|
3.7% |
5/13/2026
Event 3/31/2026
|
||
| Artisan Partners Asset Management Inc. | 3.7% | |||
| Artisan Partners Holdings LP | 3.7% | |||
| Artisan Investments GP LLC | 3.7% | |||
| Artisan Partners Limited Partnership | 3.7% | |||
|
Braidwell LP
13G/A
|
2.5% |
2/14/2025
Event 12/31/2024
|
||
| Braidwell LP | 2.5% | |||
| Braidwell Management LLC | 2.5% | |||
| Alexander T. Karnal | 2.5% | |||
| Brian J. Kreiter | 2.5% | |||
|
Venrock Healthcare Capital Partners II, L.P.
13G/A
|
0% |
2/17/2026
Event 12/31/2025
|
||
| Venrock Healthcare Capital Partners II, L.P. | 0% | |||
| VHCP Co-Investment Holdings II, LLC | 0% | |||
| VHCP Management II, LLC | 0% | |||
| Venrock Healthcare Capital Partners III, L.P. | 0% | |||
| VHCP Co-Investment Holdings III, LLC | 0% | |||
| Venrock Healthcare Capital Partners EG, L.P. | 0% | |||
| VHCP Management III, LLC | 0% | |||
| VHCP Management EG, LLC | 0% | |||
| Nimish Shah | 0% | |||
| Bong Y. Koh | 0% | |||